Target Name: NOSIP
NCBI ID: G51070
Review Report on NOSIP Target / Biomarker Content of Review Report on NOSIP Target / Biomarker
NOSIP
Other Name(s): eNOS-interacting protein | CGI-25 | Nitric oxide synthase-interacting protein (isoform 1) | nitric oxide synthase interacting protein | NOSIP variant 1 | nitric oxide synthase-interacting protein | RING-type E3 ubiquitin transferase NOSIP | Nitric oxide synthase-interacting protein | Nitric oxide synthase interacting protein, transcript variant 1 | E3 ubiquitin-protein ligase NOSIP | NOSIP_HUMAN

Discovering The Biology and Functions of NOSIP: A Potential Drug Target and Biomarker

NOSIP (Nitric Oxide-Sensitive Protein) is a protein that plays a crucial role in the regulation of blood flow and blood pressure. It is a key mediator of the cardiovascular system's response to changes in blood pressure, and it has been implicated in a number of cardiovascular diseases, including hypertension, heart failure, and cancer.

Recent studies have identified NOSIP as a potential drug target and biomarker for a number of cardiovascular and other diseases. In this article, we will explore the biology and functions of NOSIP, and discuss its potential as a drug target and biomarker.

The biology and functions of NOSIP

NOSIP is a 26-kDa protein that is expressed in a variety of tissues throughout the body, including the heart, blood vessels, kidneys, and liver. It is composed of two main subunits, a 12kDa alpha subunit and a 14kDa beta subunit. The alpha subunit is responsible for the catalytic activity of NOSIP, while the beta subunit is involved in the regulation of NOSIP's stability and interactions with other proteins.

NOSIP is involved in the regulation of a variety of physiological processes that are critical for maintaining cardiovascular and overall health. It is a key mediator of the body's response to changes in blood pressure, blood flow, and oxygen levels. It plays a role in the regulation of blood vessel diameter, blood pressure, and the production of Nitric Oxide (NO), which is a critical signaling molecule that promotes blood vessel relaxation and blood flow.

NOSIP is also involved in the regulation of cellular signaling pathways that are critical for cell survival and growth. It is a signaling molecule for the protein Pyruvate, which is involved in the production of energy by cells through the citric acid cycle. NOSIP also plays a role in the regulation of the production of reactive oxygen species (ROS), which can damage cellular components and contribute to a variety of diseases, including cancer.

In addition to its role in cardiovascular and cellular signaling pathways, NOSIP is also involved in the regulation of inflammation and immune responses. It is a potent producer of Nitric Oxide, which has been shown to have anti-inflammatory effects and to protect against the effects of certain chemotherapy drugs.

NOSIP as a drug target and biomarker

The potential of NOSIP as a drug target and biomarker for cardiovascular and other diseases has been identified through a variety of studies.

One of the main reasons for the potential of NOSIP as a drug target is its involvement in the regulation of cardiovascular and cellular signaling pathways. NOSIP has been shown to be involved in the regulation of blood vessel diameter, blood pressure, and the production of NO, which is a critical signaling molecule that promotes blood vessel relaxation and blood flow. By targeting NOSIP with drugs that can modulate its activity, researchers may be able to develop new treatments for a variety of cardiovascular and other diseases.

In addition to its role in cardiovascular and cellular signaling pathways, NOSIP is also involved in the regulation of inflammation and immune responses. It is a potent producer of Nitric Oxide, which has been shown to have anti-inflammatory effects and to protect against the effects of certain chemotherapy drugs. This suggests that NOSIP may be a useful biomarker for the assessment of therapeutic responses to drugs that target inflammation and immune responses.

Another potential use of NOSIP as a drug target is its involvement in the regulation of cellular signaling pathways that are critical for cell survival and growth. NOSIP is a signaling molecule for the protein Pyruvate, which is involved in the production of energy by cells through the citric acid cycle. By targeting NOSIP with drugs that can modulate its activity, researchers may be able to develop new treatments for a variety of cellular and genetic disorders.

Molecular mechanisms of NOSIP

The molecular mechanisms of NOSIP are complex and not fully understood. However,

Protein Name: Nitric Oxide Synthase Interacting Protein

Functions: E3 ubiquitin-protein ligase that is essential for proper development of the forebrain, the eye, and the face. Catalyzes monoubiquitination of serine/threonine-protein phosphatase 2A (PP2A) catalytic subunit PPP2CA/PPP2CB (By similarity). Negatively regulates nitric oxide production by inducing NOS1 and NOS3 translocation to actin cytoskeleton and inhibiting their enzymatic activity (PubMed:11149895, PubMed:15548660, PubMed:16135813)

The "NOSIP Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NOSIP comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

NOSTRIN | Notch ligands | Notch receptor | Notch Transcriptional Activation Complex | NOTCH1 | NOTCH2 | NOTCH2NLA | NOTCH2NLC | NOTCH3 | NOTCH4 | NOTO | NOTUM | NOVA1 | NOVA1-DT | NOVA2 | NOX1 | NOX3 | NOX4 | NOX5 | NOXA1 | NOXO1 | NOXRED1 | NPAP1 | NPAP1P2 | NPAP1P9 | NPAS1 | NPAS2 | NPAS3 | NPAS4 | NPAT | NPB | NPBWR1 | NPBWR2 | NPC1 | NPC1L1 | NPC2 | NPCDR1 | NPDC1 | NPEPL1 | NPEPPS | NPEPPSP1 | NPFF | NPFFR1 | NPFFR2 | NPHP1 | NPHP3 | NPHP3-ACAD11 | NPHP3-AS1 | NPHP4 | NPHS1 | NPHS2 | NPIPA1 | NPIPA5 | NPIPA8 | NPIPA9 | NPIPB10P | NPIPB11 | NPIPB12 | NPIPB13 | NPIPB15 | NPIPB1P | NPIPB2 | NPIPB3 | NPIPB4 | NPIPB5 | NPIPB7 | NPIPB8 | NPIPB9 | NPIPP1 | NPL | NPLOC4 | NPM1 | NPM1P13 | NPM1P21 | NPM1P22 | NPM1P25 | NPM1P27 | NPM1P28 | NPM1P35 | NPM1P42 | NPM1P47 | NPM1P48 | NPM2 | NPM3 | NPNT | NPPA | NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1